{"id":13914,"date":"2016-10-05T09:46:24","date_gmt":"2016-10-05T09:46:24","guid":{"rendered":"https:\/\/www.sygnaturediscovery.com\/sygnature-discovery-et-viramatix-nouent-une-alliance-strategique-pour-faire-progresser-la-decouverte-de-medicaments-antiviraux\/"},"modified":"2026-02-05T12:24:50","modified_gmt":"2026-02-05T12:24:50","slug":"sygnature-discovery-et-viramatix-nouent-une-alliance-strategique-pour-faire-progresser-la-decouverte-de-medicaments-antiviraux","status":"publish","type":"post","link":"https:\/\/www.sygnaturediscovery.com\/fr\/sygnature-discovery-et-viramatix-nouent-une-alliance-strategique-pour-faire-progresser-la-decouverte-de-medicaments-antiviraux\/","title":{"rendered":"Sygnature Discovery et Viramatix nouent une alliance strat\u00e9gique pour faire progresser la d\u00e9couverte de m\u00e9dicaments antiviraux"},"content":{"rendered":"

Sygnature Discovery Limited, le plus grand fournisseur ind\u00e9pendant du Royaume-Uni de ressources et d’expertise int\u00e9gr\u00e9es en mati\u00e8re de d\u00e9couverte de m\u00e9dicaments, et Viramatix Sdn. Bhd., une soci\u00e9t\u00e9 biopharmaceutique impliqu\u00e9e dans la d\u00e9couverte de traitements antiviraux \u00e0 base de peptides, ont annonc\u00e9 aujourd’hui leur collaboration en cours sur des traitements antigrippaux innovants.<\/p>\n

L’infection par le virus de la grippe demeure une grave menace pour la sant\u00e9 humaine. Chaque ann\u00e9e, pr\u00e8s de 5 millions de personnes sont gravement touch\u00e9es par cette maladie et entre 250 000 et 500 000 en d\u00e9c\u00e8dent dans le monde. \u00c0 l’heure actuelle, tr\u00e8s peu de m\u00e9dicaments sont approuv\u00e9s pour le traitement et ces options th\u00e9rapeutiques pr\u00e9sentent de nombreux inconv\u00e9nients, tels qu’une fen\u00eatre th\u00e9rapeutique courte, le d\u00e9veloppement de r\u00e9sistances virales et un spectre d’activit\u00e9 limit\u00e9. Il existe donc un besoin m\u00e9dical important non satisfait en mati\u00e8re de d\u00e9veloppement de nouvelles th\u00e9rapies dot\u00e9es de m\u00e9canismes d’action novateurs. Les candidats m\u00e9dicaments de Viramatix ont d\u00e9montr\u00e9 une excellente activit\u00e9 contre tous les types de virus de la grippe humaine, et m\u00eame contre les virus de la grippe animale et aviaire. <\/p>\n

 <\/p>\n

\"\"<\/a><\/p>\n

 <\/p>\n

 <\/p>\n

\u00ab D\u00e9localiser nos recherches n’\u00e9tait pas une d\u00e9cision \u00e0 prendre \u00e0 la l\u00e9g\u00e8re. Apr\u00e8s avoir \u00e9valu\u00e9 le march\u00e9 des CRO en Europe, Sygnature Discovery nous a particuli\u00e8rement impressionn\u00e9s par son offre de services compl\u00e8te et son \u00e9quipe performante. Leur professionnalisme et leur communication avec nos scientifiques ont \u00e9t\u00e9 d\u00e9terminants pour l’avancement de nos recherches. Gr\u00e2ce \u00e0 Sygnature Discovery, la transition vers la gestion \u00e0 distance de nos recherches s’est faite en toute fluidit\u00e9 \u00bb, explique Robert Hercus, directeur g\u00e9n\u00e9ral de Viramatix.<\/p>\n

Sygnature Discovery a d\u00e9j\u00e0 fourni des services de caract\u00e9risation DMPK et d’optimisation des principaux candidats de Viramatix<\/a> . Dans le cadre de cette collaboration, Sygnature Discovery continuera de mener diverses \u00e9tudes afin de comprendre et d’optimiser les propri\u00e9t\u00e9s pharmacologiques de ces candidats, tandis que Viramatix poursuit le d\u00e9veloppement clinique de son traitement. <\/p>\n

\u00ab Nous sommes impressionn\u00e9s par les capacit\u00e9s de Viramatix et par ses recherches, qui ont donn\u00e9 des r\u00e9sultats tr\u00e8s prometteurs concernant toutes les caract\u00e9ristiques de son traitement peptidique contre la grippe (FPT) examin\u00e9es \u00e0 ce jour \u00bb, a d\u00e9clar\u00e9 le Dr Timothy Schulz-Utermoehl, directeur du d\u00e9partement DMPK chez Sygnature Discovery. Il a ajout\u00e9 : \u00ab Nous sommes impatients de participer aux \u00e9tudes compl\u00e9mentaires de Viramatix. \u00bb<\/p>\n

\u00ab La r\u00e9ussite aussi rapide de ce projet a n\u00e9cessit\u00e9 une expertise scientifique de haut niveau et une communication fluide entre les deux groupes. Je suis ravi que Viramatix ait choisi de poursuivre et d’\u00e9tendre notre collaboration \u00bb, a d\u00e9clar\u00e9 Simon Hirst, PDG de Sygnature Discovery. \u00ab Je suis convaincu que l’alliance de l’approche novatrice de Viramatix et de l’expertise de Sygnature Discovery en mati\u00e8re de d\u00e9couverte de m\u00e9dicaments ouvre des perspectives prometteuses pour de nouvelles th\u00e9rapies. \u00bb <\/p>\n","protected":false},"excerpt":{"rendered":"","protected":false},"author":1,"featured_media":13916,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"category":[992,817],"tags":[824,825,1156,1157,1159],"class_list":["post-13914","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-dmpk","category-domaines-therapeutiques","tag-decouverte-de-la-signature","tag-decouverte-de-medicaments","tag-decouverte-de-medicaments-antiviraux","tag-partenaire","tag-viramatix"],"acf":[],"yoast_head":"\nSygnature Discovery et Viramatix nouent une alliance strat\u00e9gique pour faire progresser la d\u00e9couverte de m\u00e9dicaments antiviraux - Sygnature<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.sygnaturediscovery.com\/fr\/sygnature-discovery-et-viramatix-nouent-une-alliance-strategique-pour-faire-progresser-la-decouverte-de-medicaments-antiviraux\/\" \/>\n<meta property=\"og:locale\" content=\"fr_CA\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Sygnature Discovery et Viramatix nouent une alliance strat\u00e9gique pour faire progresser la d\u00e9couverte de m\u00e9dicaments antiviraux - Sygnature\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.sygnaturediscovery.com\/fr\/sygnature-discovery-et-viramatix-nouent-une-alliance-strategique-pour-faire-progresser-la-decouverte-de-medicaments-antiviraux\/\" \/>\n<meta property=\"og:site_name\" content=\"Sygnature\" \/>\n<meta property=\"article:published_time\" content=\"2016-10-05T09:46:24+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2026-02-05T12:24:50+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.sygnaturediscovery.com\/wp-content\/uploads\/2025\/11\/Virus-bacteria-3d-icons.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1500\" \/>\n\t<meta property=\"og:image:height\" content=\"900\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"pnpd-admin\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"\u00c9crit par\" \/>\n\t<meta name=\"twitter:data1\" content=\"pnpd-admin\" \/>\n\t<meta name=\"twitter:label2\" content=\"Estimation du temps de lecture\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.sygnaturediscovery.com\\\/fr\\\/sygnature-discovery-et-viramatix-nouent-une-alliance-strategique-pour-faire-progresser-la-decouverte-de-medicaments-antiviraux\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.sygnaturediscovery.com\\\/fr\\\/sygnature-discovery-et-viramatix-nouent-une-alliance-strategique-pour-faire-progresser-la-decouverte-de-medicaments-antiviraux\\\/\"},\"author\":{\"name\":\"pnpd-admin\",\"@id\":\"https:\\\/\\\/www.sygnaturediscovery.com\\\/fr\\\/#\\\/schema\\\/person\\\/9c173ed9f4225ab61ea895ac3a939448\"},\"headline\":\"Sygnature Discovery et Viramatix nouent une alliance strat\u00e9gique pour faire progresser la d\u00e9couverte de m\u00e9dicaments antiviraux\",\"datePublished\":\"2016-10-05T09:46:24+00:00\",\"dateModified\":\"2026-02-05T12:24:50+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.sygnaturediscovery.com\\\/fr\\\/sygnature-discovery-et-viramatix-nouent-une-alliance-strategique-pour-faire-progresser-la-decouverte-de-medicaments-antiviraux\\\/\"},\"wordCount\":542,\"publisher\":{\"@id\":\"https:\\\/\\\/www.sygnaturediscovery.com\\\/fr\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/www.sygnaturediscovery.com\\\/fr\\\/sygnature-discovery-et-viramatix-nouent-une-alliance-strategique-pour-faire-progresser-la-decouverte-de-medicaments-antiviraux\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.sygnaturediscovery.com\\\/wp-content\\\/uploads\\\/2025\\\/11\\\/Virus-bacteria-3d-icons.jpg\",\"keywords\":[\"D\u00e9couverte de la signature\",\"D\u00e9couverte de m\u00e9dicaments\",\"d\u00e9couverte de m\u00e9dicaments antiviraux\",\"partenaire\",\"viramatix\"],\"articleSection\":[\"DMPK\",\"Domaines th\u00e9rapeutiques\"],\"inLanguage\":\"fr-CA\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.sygnaturediscovery.com\\\/fr\\\/sygnature-discovery-et-viramatix-nouent-une-alliance-strategique-pour-faire-progresser-la-decouverte-de-medicaments-antiviraux\\\/\",\"url\":\"https:\\\/\\\/www.sygnaturediscovery.com\\\/fr\\\/sygnature-discovery-et-viramatix-nouent-une-alliance-strategique-pour-faire-progresser-la-decouverte-de-medicaments-antiviraux\\\/\",\"name\":\"Sygnature Discovery et Viramatix nouent une alliance strat\u00e9gique pour faire progresser la d\u00e9couverte de m\u00e9dicaments antiviraux - Sygnature\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.sygnaturediscovery.com\\\/fr\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.sygnaturediscovery.com\\\/fr\\\/sygnature-discovery-et-viramatix-nouent-une-alliance-strategique-pour-faire-progresser-la-decouverte-de-medicaments-antiviraux\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.sygnaturediscovery.com\\\/fr\\\/sygnature-discovery-et-viramatix-nouent-une-alliance-strategique-pour-faire-progresser-la-decouverte-de-medicaments-antiviraux\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.sygnaturediscovery.com\\\/wp-content\\\/uploads\\\/2025\\\/11\\\/Virus-bacteria-3d-icons.jpg\",\"datePublished\":\"2016-10-05T09:46:24+00:00\",\"dateModified\":\"2026-02-05T12:24:50+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.sygnaturediscovery.com\\\/fr\\\/sygnature-discovery-et-viramatix-nouent-une-alliance-strategique-pour-faire-progresser-la-decouverte-de-medicaments-antiviraux\\\/#breadcrumb\"},\"inLanguage\":\"fr-CA\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.sygnaturediscovery.com\\\/fr\\\/sygnature-discovery-et-viramatix-nouent-une-alliance-strategique-pour-faire-progresser-la-decouverte-de-medicaments-antiviraux\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-CA\",\"@id\":\"https:\\\/\\\/www.sygnaturediscovery.com\\\/fr\\\/sygnature-discovery-et-viramatix-nouent-une-alliance-strategique-pour-faire-progresser-la-decouverte-de-medicaments-antiviraux\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.sygnaturediscovery.com\\\/wp-content\\\/uploads\\\/2025\\\/11\\\/Virus-bacteria-3d-icons.jpg\",\"contentUrl\":\"https:\\\/\\\/www.sygnaturediscovery.com\\\/wp-content\\\/uploads\\\/2025\\\/11\\\/Virus-bacteria-3d-icons.jpg\",\"width\":1500,\"height\":900,\"caption\":\"anti-invectives||\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.sygnaturediscovery.com\\\/fr\\\/sygnature-discovery-et-viramatix-nouent-une-alliance-strategique-pour-faire-progresser-la-decouverte-de-medicaments-antiviraux\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.sygnaturediscovery.com\\\/fr\\\/page-daccueil\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Sygnature Discovery et Viramatix nouent une alliance strat\u00e9gique pour faire progresser la d\u00e9couverte de m\u00e9dicaments antiviraux\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.sygnaturediscovery.com\\\/fr\\\/#website\",\"url\":\"https:\\\/\\\/www.sygnaturediscovery.com\\\/fr\\\/\",\"name\":\"Sygnature Discovery\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/www.sygnaturediscovery.com\\\/fr\\\/#organization\"},\"alternateName\":\"Sygnature\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.sygnaturediscovery.com\\\/fr\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"fr-CA\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/www.sygnaturediscovery.com\\\/fr\\\/#organization\",\"name\":\"Sygnature Discovery\",\"url\":\"https:\\\/\\\/www.sygnaturediscovery.com\\\/fr\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-CA\",\"@id\":\"https:\\\/\\\/www.sygnaturediscovery.com\\\/fr\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/www.sygnaturediscovery.com\\\/wp-content\\\/uploads\\\/2025\\\/11\\\/Logo.svg\",\"contentUrl\":\"https:\\\/\\\/www.sygnaturediscovery.com\\\/wp-content\\\/uploads\\\/2025\\\/11\\\/Logo.svg\",\"width\":1,\"height\":1,\"caption\":\"Sygnature Discovery\"},\"image\":{\"@id\":\"https:\\\/\\\/www.sygnaturediscovery.com\\\/fr\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.sygnaturediscovery.com\\\/fr\\\/#\\\/schema\\\/person\\\/9c173ed9f4225ab61ea895ac3a939448\",\"name\":\"pnpd-admin\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-CA\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/052476d339a267f4be89460f64dd24ba52137529feafa9cf45d6e8b2b62cda8b?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/052476d339a267f4be89460f64dd24ba52137529feafa9cf45d6e8b2b62cda8b?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/052476d339a267f4be89460f64dd24ba52137529feafa9cf45d6e8b2b62cda8b?s=96&d=mm&r=g\",\"caption\":\"pnpd-admin\"},\"sameAs\":[\"http:\\\/\\\/www.sygnaturediscovery.com\"]}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Sygnature Discovery et Viramatix nouent une alliance strat\u00e9gique pour faire progresser la d\u00e9couverte de m\u00e9dicaments antiviraux - Sygnature","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.sygnaturediscovery.com\/fr\/sygnature-discovery-et-viramatix-nouent-une-alliance-strategique-pour-faire-progresser-la-decouverte-de-medicaments-antiviraux\/","og_locale":"fr_CA","og_type":"article","og_title":"Sygnature Discovery et Viramatix nouent une alliance strat\u00e9gique pour faire progresser la d\u00e9couverte de m\u00e9dicaments antiviraux - Sygnature","og_url":"https:\/\/www.sygnaturediscovery.com\/fr\/sygnature-discovery-et-viramatix-nouent-une-alliance-strategique-pour-faire-progresser-la-decouverte-de-medicaments-antiviraux\/","og_site_name":"Sygnature","article_published_time":"2016-10-05T09:46:24+00:00","article_modified_time":"2026-02-05T12:24:50+00:00","og_image":[{"width":1500,"height":900,"url":"https:\/\/www.sygnaturediscovery.com\/wp-content\/uploads\/2025\/11\/Virus-bacteria-3d-icons.jpg","type":"image\/jpeg"}],"author":"pnpd-admin","twitter_card":"summary_large_image","twitter_misc":{"\u00c9crit par":"pnpd-admin","Estimation du temps de lecture":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.sygnaturediscovery.com\/fr\/sygnature-discovery-et-viramatix-nouent-une-alliance-strategique-pour-faire-progresser-la-decouverte-de-medicaments-antiviraux\/#article","isPartOf":{"@id":"https:\/\/www.sygnaturediscovery.com\/fr\/sygnature-discovery-et-viramatix-nouent-une-alliance-strategique-pour-faire-progresser-la-decouverte-de-medicaments-antiviraux\/"},"author":{"name":"pnpd-admin","@id":"https:\/\/www.sygnaturediscovery.com\/fr\/#\/schema\/person\/9c173ed9f4225ab61ea895ac3a939448"},"headline":"Sygnature Discovery et Viramatix nouent une alliance strat\u00e9gique pour faire progresser la d\u00e9couverte de m\u00e9dicaments antiviraux","datePublished":"2016-10-05T09:46:24+00:00","dateModified":"2026-02-05T12:24:50+00:00","mainEntityOfPage":{"@id":"https:\/\/www.sygnaturediscovery.com\/fr\/sygnature-discovery-et-viramatix-nouent-une-alliance-strategique-pour-faire-progresser-la-decouverte-de-medicaments-antiviraux\/"},"wordCount":542,"publisher":{"@id":"https:\/\/www.sygnaturediscovery.com\/fr\/#organization"},"image":{"@id":"https:\/\/www.sygnaturediscovery.com\/fr\/sygnature-discovery-et-viramatix-nouent-une-alliance-strategique-pour-faire-progresser-la-decouverte-de-medicaments-antiviraux\/#primaryimage"},"thumbnailUrl":"https:\/\/www.sygnaturediscovery.com\/wp-content\/uploads\/2025\/11\/Virus-bacteria-3d-icons.jpg","keywords":["D\u00e9couverte de la signature","D\u00e9couverte de m\u00e9dicaments","d\u00e9couverte de m\u00e9dicaments antiviraux","partenaire","viramatix"],"articleSection":["DMPK","Domaines th\u00e9rapeutiques"],"inLanguage":"fr-CA"},{"@type":"WebPage","@id":"https:\/\/www.sygnaturediscovery.com\/fr\/sygnature-discovery-et-viramatix-nouent-une-alliance-strategique-pour-faire-progresser-la-decouverte-de-medicaments-antiviraux\/","url":"https:\/\/www.sygnaturediscovery.com\/fr\/sygnature-discovery-et-viramatix-nouent-une-alliance-strategique-pour-faire-progresser-la-decouverte-de-medicaments-antiviraux\/","name":"Sygnature Discovery et Viramatix nouent une alliance strat\u00e9gique pour faire progresser la d\u00e9couverte de m\u00e9dicaments antiviraux - Sygnature","isPartOf":{"@id":"https:\/\/www.sygnaturediscovery.com\/fr\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.sygnaturediscovery.com\/fr\/sygnature-discovery-et-viramatix-nouent-une-alliance-strategique-pour-faire-progresser-la-decouverte-de-medicaments-antiviraux\/#primaryimage"},"image":{"@id":"https:\/\/www.sygnaturediscovery.com\/fr\/sygnature-discovery-et-viramatix-nouent-une-alliance-strategique-pour-faire-progresser-la-decouverte-de-medicaments-antiviraux\/#primaryimage"},"thumbnailUrl":"https:\/\/www.sygnaturediscovery.com\/wp-content\/uploads\/2025\/11\/Virus-bacteria-3d-icons.jpg","datePublished":"2016-10-05T09:46:24+00:00","dateModified":"2026-02-05T12:24:50+00:00","breadcrumb":{"@id":"https:\/\/www.sygnaturediscovery.com\/fr\/sygnature-discovery-et-viramatix-nouent-une-alliance-strategique-pour-faire-progresser-la-decouverte-de-medicaments-antiviraux\/#breadcrumb"},"inLanguage":"fr-CA","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.sygnaturediscovery.com\/fr\/sygnature-discovery-et-viramatix-nouent-une-alliance-strategique-pour-faire-progresser-la-decouverte-de-medicaments-antiviraux\/"]}]},{"@type":"ImageObject","inLanguage":"fr-CA","@id":"https:\/\/www.sygnaturediscovery.com\/fr\/sygnature-discovery-et-viramatix-nouent-une-alliance-strategique-pour-faire-progresser-la-decouverte-de-medicaments-antiviraux\/#primaryimage","url":"https:\/\/www.sygnaturediscovery.com\/wp-content\/uploads\/2025\/11\/Virus-bacteria-3d-icons.jpg","contentUrl":"https:\/\/www.sygnaturediscovery.com\/wp-content\/uploads\/2025\/11\/Virus-bacteria-3d-icons.jpg","width":1500,"height":900,"caption":"anti-invectives||"},{"@type":"BreadcrumbList","@id":"https:\/\/www.sygnaturediscovery.com\/fr\/sygnature-discovery-et-viramatix-nouent-une-alliance-strategique-pour-faire-progresser-la-decouverte-de-medicaments-antiviraux\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.sygnaturediscovery.com\/fr\/page-daccueil\/"},{"@type":"ListItem","position":2,"name":"Sygnature Discovery et Viramatix nouent une alliance strat\u00e9gique pour faire progresser la d\u00e9couverte de m\u00e9dicaments antiviraux"}]},{"@type":"WebSite","@id":"https:\/\/www.sygnaturediscovery.com\/fr\/#website","url":"https:\/\/www.sygnaturediscovery.com\/fr\/","name":"Sygnature Discovery","description":"","publisher":{"@id":"https:\/\/www.sygnaturediscovery.com\/fr\/#organization"},"alternateName":"Sygnature","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.sygnaturediscovery.com\/fr\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"fr-CA"},{"@type":"Organization","@id":"https:\/\/www.sygnaturediscovery.com\/fr\/#organization","name":"Sygnature Discovery","url":"https:\/\/www.sygnaturediscovery.com\/fr\/","logo":{"@type":"ImageObject","inLanguage":"fr-CA","@id":"https:\/\/www.sygnaturediscovery.com\/fr\/#\/schema\/logo\/image\/","url":"https:\/\/www.sygnaturediscovery.com\/wp-content\/uploads\/2025\/11\/Logo.svg","contentUrl":"https:\/\/www.sygnaturediscovery.com\/wp-content\/uploads\/2025\/11\/Logo.svg","width":1,"height":1,"caption":"Sygnature Discovery"},"image":{"@id":"https:\/\/www.sygnaturediscovery.com\/fr\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/www.sygnaturediscovery.com\/fr\/#\/schema\/person\/9c173ed9f4225ab61ea895ac3a939448","name":"pnpd-admin","image":{"@type":"ImageObject","inLanguage":"fr-CA","@id":"https:\/\/secure.gravatar.com\/avatar\/052476d339a267f4be89460f64dd24ba52137529feafa9cf45d6e8b2b62cda8b?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/052476d339a267f4be89460f64dd24ba52137529feafa9cf45d6e8b2b62cda8b?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/052476d339a267f4be89460f64dd24ba52137529feafa9cf45d6e8b2b62cda8b?s=96&d=mm&r=g","caption":"pnpd-admin"},"sameAs":["http:\/\/www.sygnaturediscovery.com"]}]}},"_links":{"self":[{"href":"https:\/\/www.sygnaturediscovery.com\/fr\/wp-json\/wp\/v2\/posts\/13914","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.sygnaturediscovery.com\/fr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.sygnaturediscovery.com\/fr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.sygnaturediscovery.com\/fr\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.sygnaturediscovery.com\/fr\/wp-json\/wp\/v2\/comments?post=13914"}],"version-history":[{"count":0,"href":"https:\/\/www.sygnaturediscovery.com\/fr\/wp-json\/wp\/v2\/posts\/13914\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.sygnaturediscovery.com\/fr\/wp-json\/wp\/v2\/media\/13916"}],"wp:attachment":[{"href":"https:\/\/www.sygnaturediscovery.com\/fr\/wp-json\/wp\/v2\/media?parent=13914"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.sygnaturediscovery.com\/fr\/wp-json\/wp\/v2\/category?post=13914"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.sygnaturediscovery.com\/fr\/wp-json\/wp\/v2\/tags?post=13914"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}